Meet Our Team

Before Tenomix: Ph.D. in Pathology and Laboratory Medicine from Western University. Medical Innovation Fellow and scientist-entrepreneur with 10+ years of experience in diagnostics, translational research, and commercialization. Raised $4M+ in funding, published 16+ papers, and built clinical partnerships with top-tier hospitals across North America. Recipient of multiple competitive awards in business, research, and healthcare innovation.

Why Tenomix: "Tenomix was born out of something deeply personal. I lost 2 close aunts at a young age due to late-stage cancer diagnosis — a situation that might have been different if the right medical tools were available at the time. On the other hand, I've also seen how medical innovation transformed the quality of life for my younger brother. Those experiences have shaped how I think about impact. Innovation in healthcare isn't just about technology — it's about real people, families, physicians, hospitals, and outcomes. At Tenomix, we're focused on developing thoughtful, practical solutions that can support clinical teams and improve patient care. By combining robotics, imaging, and AI, our goal is to make a meaningful difference in how pathology workflows are supported — helping reduce strain on staff, improve consistency, and ultimately enhance decision-making for better cancer care."

Before Tenomix: Physician-scientist with an MD from the Netherlands and a PhD in Kinesiology/Neuroscience from the University of British Columbia, where I focused on balance control in people with neurological disorders. I joined the Medical Innovation Fellowship at Western University as a Fellow and later served as Interim Director, leading a multidisciplinary team through identifying clinical needs, then building and validating early-stage medical technologies. That experience—working across disciplines, listening closely to users, and translating real-world problems into practical solutions—shaped how I approach building our technology and company operations at Tenomix today.

Why Tenomix: "I co-founded Tenomix because I believed in the solution we were developing, and every day I see us getting closer to having our device make an impact where it matters—in pathology labs. Providing pathology staff with the right tools at the right time—tools that fit within their workflow—supports them in delivering high-quality cancer care to patients. That ability to have a real impact comes from how much we care, how closely we listen, and how we tackle challenges together as a team with different but complementary perspectives."

Before Tenomix: Director of Engineering at Aufero Medical - Robotic surgical system ensuring ablation catheter stability for cardiac/EP applications, first FTE through to animal studies in collaboration with a major multinational. Several other engineering engagements including applications in home health care devices (IoT), orthopedic implants, and respiratory care.

Why Tenomix: "I am incredibly passionate about building novel, impactful technology. From learned experience I can attest that if innovation is to have impact, it must not only solve a problem, but also ensure all the stakeholders involved have their needs met. Simply - Tenomix is built ground-up to consider everyone who will purchase, use, or receive care from our products before we design anything, and frequent feedback is always a priority. Combining this mentality with an incredible team is the foundation of an incredible, sustainable and impactful business which I'm honored to play my part in every day."

Before Tenomix: Sherif is a seasoned entrepreneur and engineer with over 20 years of experience turning innovative ideas into impactful technologies. He co-founded and led multiple startups, including FloNergia Systems and Smart Perceptions, where he developed and commercialized products across cleantech and engineering simulation domains. His entrepreneurial journey is grounded in deep technical expertise, with a PhD in Mechanical Engineering and a specialization in CFD and microfluidic systems. Alongside his ventures, he held leadership roles at Mohawk College, advancing applied research in healthcare and manufacturing innovation.

Why Tenomix: "After years of navigating the challenges of engineering innovation, I saw in Tenomix a rare opportunity to translate clinical needs directly into impactful solutions. We're not just building devices—we're reshaping how cancer care is delivered, and I wanted to be part of that change from the ground up."

Before Tenomix: Founded 7 companies, including Founding CTO at Lablight AR - procedural guidance for lab workers using augmented reality, Founding CEO and Computer Vision Lead at GestSure - touchless interface for surgeons in the operating room. University of Waterloo, BASc in Mechatronics Engineering.

Why Tenomix: "Throughout my career, I've been driven by the desire to build technologies and tools that solve real-world problems and create meaningful impact. Tenomix represents the culmination of that passion. It allows me to leverage my experience in robotics, computer vision, and medical devices to contribute to a solution that will fundamentally improve a critical aspect of healthcare."

Before Tenomix: PhD in Biomedical Engineering Robotics - improving wearable rehabilitation robotics using bioelectrical signal processing, machine learning, and sensor fusion to develop EEG-EMG fusion-based classifiers integrated into device control systems. Mechanical Engineering Intern at Trudell Medical International - supporting development of medical devices for respiratory care. Robotics club president during Mechatronic Systems Engineering undergraduate degree.

Why Tenomix: "I love having the opportunity to develop interesting novel technology and solve challenging problems with the amazing team here at Tenomix. Everyone is working hard towards our shared goal of automating the pathology space using AI-driven medical robotics, and seeing what the team has accomplished in such a short amount of time has been nothing short of inspiring. I am grateful that my passion for mechatronics and biomedical robotics can be used to support this mission and I feel proud knowing that the work we are doing here will help better the lives of cancer patients through a more efficient clinical workflow."

Before Tenomix: Developed wearable biofeedback systems for gait rehabilitation, focusing on sensor integration, real-time data acquisition, and signal processing. Led the design and optimization of a wearable medical device, ensuring seamless integration into clinical environments for user-friendly patient outcomes. Completed a Master's in Biomedical Engineering, with a focus on real-time indoor positioning and sensor integration in healthcare applications for older adults.

Why Tenomix: "I joined Tenomix because I'm passionate about using technology to improve healthcare outcomes. The opportunity to work on cutting edge solutions that directly impact patient care really resonated with me. What excites me most is being part of a team that's dedicated to pushing the boundaries of what's possible in clinical diagnostics, especially with the integration of AI and robotics. I'm eager to contribute to projects that not only innovate but also deliver practical, life-changing solutions for patients and clinicians alike."

Before Tenomix: Experience in regulatory and medical communications across public and private sectors. MSc in Regulatory Affairs and B.Eng in Biomedical Engineering.

Why Tenomix: "Tenomix stood out to me as a company genuinely focused on improving patient care. I saw an opportunity to grow while helping shape the path to market for innovative technologies with real-world impact."

Before Tenomix: Research Assistant at The Hospital for Sick Children and Research Intern at the National Institute of Genetics in Japan. During her HBSc at the University of Toronto, she also held leadership roles in community outreach and mentorship.

Why Tenomix: "After spending a lot of time at the bench doing wet lab research, I felt a strong pull to explore the 'bedside' side of science—where innovation directly meets patient care, especially in the cancer space. I've always had a wide range of interests beyond science, from marketing to design to strategy, and I knew I wanted to grow in a role that would let me explore all of them. Tenomix, as a mission-driven startup, gave me the perfect opportunity to contribute to meaningful innovation while learning what it really takes to build something from the ground up."

Before Tenomix: Studied Applied Genetics & Molecular Biology at the University of Toronto. Led iGEM Toronto's entrepreneurship team to global recognition (2023 nomination, 2024 win). Participated in multiple incubator and pre-accelerator cohorts, and served as a business associate at PRiME Precision Medicine Institute at UofT. Former founder of multiple University of Toronto associations serving the undergraduate community. Has past experience in successful entrepreneurial pursuits, including a 6-figure exit in the small business space.

Why Tenomix: "Having seen the impact of cancer firsthand, I joined Tenomix because its mission to expedite cancer staging and improve patient outcomes, deeply aligns with my belief that medical technology, innovation, and entrepreneurship should drive real-world impact. Tenomix is uniquely positioned to transform cancer care, and I'm proud to be part and contribute to that mission. It's time for us to give cancer the kick it deserves."

Before Tenomix: Ketan is currently pursuing a degree at the Ivey Business School after completing two years in Health Sciences at Queen's University. He previously worked with another early-stage medtech startup as well as the London Health Sciences Centre, where he gained hands-on experience in business development and strategy.

Why Tenomix: "I've always been excited by the challenge of building something from the ground up and hope to one day pursue my own entrepreneurial path. To prepare for that, I wanted to be part of a startup where I could learn from experienced mentors, have real ownership over my work, and play a role in shaping the company's future. Tenomix stood out because of its mission-driven team, open and collaborative culture, and the chance to contribute meaningfully to a fast-moving venture. It's a place where I've been able to take on impactful projects, build lasting relationships, and grow in the ways that matter most to me."

Before Tenomix: Final year HBSc student at the University of Toronto, double majoring in Applied Genetics & Biotechnology and Psychology, minoring in Immunology and pursuing a Certificate in Business from the Rotman School of Management.

Why Tenomix: "I believe Tenomix is addressing one of the most pressing challenges in healthcare today. Pathology challenges not only slow treatment but also create disparities in care, especially for underserved communities. By combining robotics, imaging, and AI, Tenomix is developing a new approach to pathology that streamlines workflows and expands access. This technology has the potential to improve cancer diagnostics, accelerating treatment timelines and improving equity. The chance to contribute to such meaningful work is why I am excited about Tenomix."